StockClub

SXTP

SXTP60 Degrees Pharmaceuticals, Inc.$ --
60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc.

SXTP

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
0M USD
YoY +223.4%
Operating Income
-2M USD
YoY -9.8%
Net Income
-2M USD
YoY -7.3%
EPS
-2.52$
YoY +28.4%

Revenue

$702,086
FY2023 Q4$170,599
$170,599
Q4
FY2024 Q1$105,674
$105,674
Q1
FY2024 Q2$230,646
$230,646
Q2
FY2024 Q3$365,939
$365,939
Q3
FY2024 Q4$627,379
$627,379
Q4
FY2025 Q1$163,552
$163,552
Q1
FY2025 Q2$264,484
$264,484
Q2
FY2025 Q3$702,086
$702,086
Q3
Actual
+$336,147 (+91.9%)

Net Income

$-5.9M
FY2023 Q4$-3.7M
$-3.7M
Q4
FY2024 Q1$430,470
$430,470
Q1
FY2024 Q2$-3.7M
$-3.7M
Q2
FY2024 Q3$-5.9M
$-5.9M
Q3
FY2024 Q4$-8M
$-8M
Q4
FY2025 Q1$-1.9M
$-1.9M
Q1
FY2025 Q2$-3.6M
$-3.6M
Q2
FY2025 Q3$-5.9M
$-5.9M
Q3
Actual
$-25,241 (-0.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$2.2M
FY2020
$2.2M
FY2021
Actual:$1.2M
FY2021
$1.2M
FY2022
Actual:$223,208
FY2022
$223,208
FY2023BEAT
Actual:$253,573
Est:$250,000
FY2023BEAT
$253,573
FY2024BEAT
Actual:$607,574
Est:$600,000
FY2024BEAT
$607,574

Analyst Estimates